Skip to main content

Peer Review reports

From: A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran

Original Submission
19 May 2023 Submitted Original manuscript
17 Jun 2023 Author responded Author comments - Farid Najafi
Resubmission - Version 2
17 Jun 2023 Submitted Manuscript version 2
21 Jun 2023 Author responded Author comments - Farid Najafi
Resubmission - Version 3
21 Jun 2023 Submitted Manuscript version 3
Publishing
8 Jul 2023 Editorially accepted
24 Jul 2023 Article published 10.1186/s12889-023-16265-8

You can find further information about peer review here.

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us